Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,718 | 16,532 | 19,276 | 22,850 | 26,250 |
| TOTAL | $13,944 | $16,927 | $19,834 | $23,576 | $26,484 |
| Non-Current Assets | |||||
| PPE Net | 65 | 71 | 76 | 82 | 87 |
| Other Non-Current Assets | 312 | 312 | 312 | 322 | 323 |
| TOTAL | $377 | $383 | $388 | $403 | $410 |
| Total Assets | $14,321 | $17,310 | $20,222 | $23,980 | $26,894 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 641 | 1,196 | 1,282 | 1,352 | 1,154 |
| Accrued Expenses | 2,040 | 1,972 | 2,079 | 2,009 | 2,482 |
| TOTAL | $2,681 | $3,168 | $3,361 | $3,361 | $3,636 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 727 | 727 | 1,311 | 1,311 | 1,311 |
| TOTAL | $727 | $727 | $1,311 | $1,311 | $1,311 |
| Total Liabilities | $3,409 | $3,895 | $4,672 | $4,672 | $4,947 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,311 | 5,825 | 5,531 | 5,492 | 5,435 |
| Common Shares | 6 | 6 | 6 | 6 | 5 |
| Retained earnings | -331,186 | -328,213 | -324,975 | -321,042 | -318,147 |
| Other shareholders' equity | -10,630 | -10,628 | -10,627 | -10,627 | -10,605 |
| TOTAL | $10,913 | $13,415 | $15,550 | $19,308 | $21,947 |
| Total Liabilities And Equity | $14,321 | $17,310 | $20,222 | $23,980 | $26,894 |